Literature DB >> 15166434

Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver.

Søren U Nielsen1, Margaret F Bassendine1, Alastair D Burt2,1, Debra J Bevitt1, Geoffrey L Toms1.   

Abstract

In the absence of satisfactory cell culture systems for hepatitis C virus (HCV), virtually all that is known about the proteins of the virus has been learned by the study of recombinant proteins. Characterization of virus proteins from patients with HCV has been retarded by the low virus titre in blood and limited availability of infected tissue. Here, the authors have identified a primary infection in a liver transplanted into an immunodeficient patient with chronic HCV. The patient required re-transplant and the infected liver, removed 6 weeks after the initial transplant, had a very high titre of HCV, 5 x 10(9) International Units (IU) per gram of liver. The density distribution of HCV in iodixanol gradients showed a peak at 1.04 g x ml(-1) with 73 % of virus below 1.08 g x ml(-1). Full-length HCV RNA was detected by Northern blotting and the ratio between positive- and negative-strand HCV RNA was determined as 60. HCV was partially purified by precipitation with heparin/Mn(2+) and a single species of each of the three structural proteins, core, E1 and E2, was detected by Western blotting. The molecular mass of core was 20 kDa, which corresponds to the mature form from recombinant sources. The molecular mass of glycoprotein E1 was 31 kDa before and 21 kDa after deglycosylation with PNGase F or endoglycosidase H. Glycoprotein E2 was 62 kDa before and 36 kDa after deglycosylation, but E2-P7 was not detected. This was in contrast to recombinant sources of E2 which contain E2-P7.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166434      PMCID: PMC1810391          DOI: 10.1099/vir.0.79967-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  50 in total

Review 1.  Folding, assembly and subcellular localization of hepatitis C virus glycoproteins.

Authors:  J Dubuisson
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

Review 2.  The outcome of hepatitis C virus infection after liver transplantation--is it influenced by the type of immunosuppression?

Authors:  G V Papatheodoridis; D Patch; G M Dusheiko; A K Burroughs
Journal:  J Hepatol       Date:  1999-04       Impact factor: 25.083

3.  Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.

Authors:  R Thomssen; S Bonk; A Thiele
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

4.  Regulated processing of hepatitis C virus core protein is linked to subcellular localization.

Authors:  Q Liu; C Tackney; R A Bhat; A M Prince; P Zhang
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen.

Authors:  K Aoyagi; C Ohue; K Iida; T Kimura; E Tanaka; K Kiyosawa; S Yagi
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  The native form and maturation process of hepatitis C virus core protein.

Authors:  K Yasui; T Wakita; K Tsukiyama-Kohara; S I Funahashi; M Ichikawa; T Kajita; D Moradpour; J R Wands; M Kohara
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

8.  Detection of the putative E2 protein of hepatitis C virus in human liver.

Authors:  Y Nakamoto; S Kaneko; M Honda; M Unoura; J Cheong; A Harada; K Matsushima; K Kobayashi; S Murakami
Journal:  J Med Virol       Date:  1994-04       Impact factor: 2.327

9.  Expression and identification of hepatitis C virus polyprotein cleavage products.

Authors:  A Grakoui; C Wychowski; C Lin; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins.

Authors:  A M Prince; T Huima-Byron; T S Parker; D M Levine
Journal:  J Viral Hepat       Date:  1996-01       Impact factor: 3.728

View more
  24 in total

1.  Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.

Authors:  Olivier Diaz; François Delers; Marianne Maynard; Sylvie Demignot; Fabien Zoulim; Jean Chambaz; Christian Trépo; Vincent Lotteau; Patrice André
Journal:  J Gen Virol       Date:  2006-10       Impact factor: 3.891

2.  Hepatitis C virus e2 protein ectodomain is essential for assembly of infectious virions.

Authors:  Alessia Bianchi; Stefania Crotta; Michela Brazzoli; Steven K H Foung; Marcello Merola
Journal:  Int J Hepatol       Date:  2010-10-12

3.  Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.

Authors:  Vinca Icard; Olivier Diaz; Caroline Scholtes; Laure Perrin-Cocon; Christophe Ramière; Ralf Bartenschlager; Francois Penin; Vincent Lotteau; Patrice André
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

4.  Binding of liver derived, low density hepatitis C virus to human hepatoma cells.

Authors:  Caroline Martin; Soren U Nielsen; Siti Ibrahim; Margaret F Bassendine; Geoffrey L Toms
Journal:  J Med Virol       Date:  2008-05       Impact factor: 2.327

5.  Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies.

Authors:  Joe Grove; Søren Nielsen; Jin Zhong; Margaret F Bassendine; Heidi E Drummer; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

6.  Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Caroline Martin; Wanna Pumeechockchai; Geoffrey L Toms
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation.

Authors:  F Fenwick; M F Bassendine; K Agarwal; D Bevitt; W Pumeechockchai; A D Burt; G L Toms
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

8.  HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development.

Authors:  Sobia Idrees; Usman A Ashfaq; Saba Khaliq
Journal:  J Transl Med       Date:  2013-04-30       Impact factor: 5.531

Review 9.  Hepatitis C virus: virology and life cycle.

Authors:  Chang Wook Kim; Kyong-Mi Chang
Journal:  Clin Mol Hepatol       Date:  2013-03-25

Review 10.  Primary hepatocytes as targets for hepatitis C virus replication.

Authors:  M J Farquhar; J A McKeating
Journal:  J Viral Hepat       Date:  2008-12       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.